Terkeltaub R, Smeltzer D, Curtiss L K, Ginsberg M H
Arthritis Rheum. 1986 Mar;29(3):363-70. doi: 10.1002/art.1780290309.
Low density lipoprotein (LDL) is the major plasma inhibitor of neutrophil oxidative and lytic responses to monosodium urate crystals and may function to modulate acute gouty inflammation. LDL inhibited apparent phagocytosis of urate crystals by human neutrophils, suggesting it may interfere with early events in the crystal-induced stimulation of neutrophils. The effects were not specific for neutrophils, since human platelet secretory and membranolytic responses to urate crystals were also inhibited by purified LDL in doses as low as 10 micrograms/ml. As with neutrophils, the inhibitory activity of LDL was stimulus-specific. Since LDL binds to urate crystals and specifically inhibits a range of cellular responses to them, including phagocytosis, we hypothesized that LDL interferes with the initial crystal-cell interaction. We measured platelet interaction with urate crystals and found that LDL was a potent inhibitor of crystal-induced platelet sedimentation and was 10-100-fold more active than lipoprotein-depleted plasma or purified high density lipoprotein. In summary, LDL inhibits a broad range of responses of a number of inflammatory cell types to certain inflammatory surfaces, and this effect appears to be due to inhibition of physical association of crystals with cell membranes.
低密度脂蛋白(LDL)是中性粒细胞对尿酸钠晶体氧化和溶解反应的主要血浆抑制剂,可能在调节急性痛风性炎症中发挥作用。LDL抑制人中性粒细胞对尿酸盐晶体的明显吞噬作用,提示其可能干扰晶体诱导的中性粒细胞刺激的早期事件。这些作用并非中性粒细胞所特有,因为纯化的LDL低至10微克/毫升的剂量就能抑制人血小板对尿酸盐晶体的分泌和膜溶解反应。与中性粒细胞一样,LDL的抑制活性具有刺激特异性。由于LDL与尿酸盐晶体结合并特异性抑制一系列对其的细胞反应,包括吞噬作用,我们推测LDL会干扰晶体与细胞的初始相互作用。我们测量了血小板与尿酸盐晶体的相互作用,发现LDL是晶体诱导的血小板沉降的有效抑制剂,其活性比脂蛋白缺乏血浆或纯化的高密度脂蛋白高10至100倍。总之,LDL抑制多种炎症细胞类型对某些炎症表面的广泛反应,这种作用似乎是由于抑制了晶体与细胞膜的物理结合。